Publication

The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Vinita Singh, Emory UniversityMansoor M Aman, Advocate Aurora HealthAmmar Mahmoud, Northern Light Health Eastern Maine Medical CenterTimothy Deer, The Spine and Nerve Center of the VirginiasDawood Sayed, University of KansasJonathan M Hagedorn, Mayo Clinic, RochesterShane E Brogan, University of UtahAmitabh Gulati, Memorial Sloan Kettering Cancer CenterNatalie Strand, Mayo Clinic, PhoenixJacqueline Weisbein, University of Arkansas Medical SciencesJohnathan H Goree, Napa Valley Orthopedic Medical GroupFangfang Xing, Swedish Health ServicesAli Valimahomed, Gramercy Pain CenterDaniel J Pak, New York-Presbyterian HospitalAntonios El Helou, Moncton HospPriyanka Ghosh, Remedy Medical GroupKrishna Shah, Baylor College of MedicineVishal Patel, Advocate Aurora HealthAlexander Escobar, University of ToledoKeith Schmidt, St. Alexius Medical CenterJay Shah, SamWell Inst Pain ManagementVishal Varshney, Providence HealthcareWilliam Rosenberg, Midwest Neurosurg AssociatesSanjeet Narang, Harvard Medical School
Language
  • English
Date
  • 2021-01-01
Publisher
  • DOVE MEDICAL PRESS LTD
Publication Version
Copyright Statement
  • © 2021 Aman et al.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 14
Start Page
  • 2139
End Page
  • 2164
Abstract
  • Moderate to severe pain occurs in many cancer patients during their clinical course and may stem from the primary pathology, metastasis, or as treatment side effects. Uncontrolled pain using conservative medical therapy can often lead to patient distress, loss of productivity, shorter life expectancy, longer hospital stays, and increase in healthcare utilization. Various publications shed light on strategies for conservative medical management for cancer pain and a few international publications have reviewed limited interventional data. Our multi-institutional working group was assembled to review and highlight the body of evidence that exists for opioid utilization for cancer pain, adjunct medication such as ketamine and methadone and interventional therapies. We discuss neurolysis via injections, neuromodulation including targeted drug delivery and spinal cord stimulation, vertebral tumor ablation and augmentation, radiotherapy and surgical techniques. In the United States, there is a significant variance in the interventional treatment of cancer pain based on fellowship training. As a first of its kind, this best practices and interventional guideline will offer evidenced-based recommendations for reducing pain and suffering associated with malignancy.
Author Notes
  • Mansoor M Aman Interventional Pain Medicine, Department of Anesthesiology, Advocate Aurora Health, Oshkosh, WI, 54904, USA, Phone: Tel +1 920-456-7715, Email aman.mansoorm@gmail.com
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items